Differentiation of odontoblasts is negatively regulated by MEPE via its C-terminal fragment

Biochemical and Biophysical Research Communications

Volumn 398, Issue 3, 2010, Pages 406-412

  Wang, Hanguo ^a   Kawashima, Nobuyuki ^b   Iwata, Takanori ^c   Xu, Jing ^b   Takahashi, Satomi ^b   Sugiyama, Toshihiro ^d   Suda, Hideaki ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d AKITA UNIVERSITY   (Japan)

Author keywords

Dental pulp tissue; Differentiation; MEPE; Odontoblast; Proteolytic cleavage; Small integrin binding ligand N linked glycoprotein

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CONTROLLED STUDY; MOLAR TOOTH; NEWBORN; NONHUMAN; ODONTOBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RAT; TOOTH DEVELOPMENT; TOOTH PULP;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; DENTINOGENESIS; EXTRACELLULAR MATRIX PROTEINS; GENE KNOCKDOWN TECHNIQUES; GLYCOPROTEINS; HUMANS; MICE; ODONTOBLASTS; PHOSPHOPROTEINS; PROTEIN STRUCTURE, TERTIARY;

EUKARYOTA; RATTUS NORVEGICUS;

EID: 77955274335     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.085     Document Type: Article

References (38)

1. Rowe P.S., de Zoysa P.A., Dong R., Wang H.R., White K.E., Econs M.J., Oudet C.L. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. Genomics 2000, 67:54-68.
2. Argiro L., Desbarats M., Glorieux F.H., Ecarot B. Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone. Genomics 2001, 74:342-351.
3. Petersen D.N., Tkalcevic G.T., Mansolf A.L., Rivera-Gonzalez R., Brown T.A. Identification of osteoblast/osteocyte factor 45 (OF45), a bone-specific cDNA encoding an RGD-containing protein that is highly expressed in osteoblasts and osteocytes. J. Biol. Chem. 2000, 275:36172-36180.
4. Lu C., Huang S., Miclau T., Helms J.A., Colnot C. Mepe is expressed during skeletal development and regeneration. Histochem. Cell Biol. 2004, 121:493-499.
5. Liu H., Li W., Gao C., Kumagai Y., Blacher R.W., DenBesten P.K. Dentonin, a fragment of MEPE, enhanced dental pulp stem cell proliferation. J. Dent. Res. 2004, 83:496-499.
6. Six N., Septier D., Chaussain-Miller C., Blacher R., DenBesten P., Goldberg M. Dentonin, a MEPE fragment, initiates pulp-healing response to injury. J. Dent. Res. 2007, 86:780-785.
7. Gowen L.C., Petersen D.N., Mansolf A.L., Qi H., Stock J.L., Tkalcevic G.T., Simmons H.A., Crawford D.T., Chidsey-Frink K.L., Ke H.Z., McNeish J.D., Brown T.A. Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J. Biol. Chem. 2003, 278:1998-2007.
8. MacDougall M., Simmons D., Gu T.T., Dong J. MEPE/OF45, a new dentin/bone matrix protein and candidate gene for dentin diseases mapping to chromosome 4q21. Connect. Tissue Res. 2002, 43:320-330.
9. Liu H., Li W., Shi S., Habelitz S., Gao C., Denbesten P. MEPE is downregulated as dental pulp stem cells differentiate. Arch. Oral Biol. 2005, 50:923-928.
10. Jain A., Fedarko N.S., Collins M.T., Gelman R., Ankrom M.A., Tayback M., Fisher L.W. Serum levels of matrix extracellular phosphoglycoprotein (MEPE) in normal humans correlate with serum phosphorus, parathyroid hormone and bone mineral density. J. Clin. Endocrinol. Metab. 2004, 89:4158-4161.
11. Berndt T.J., Schiavi S., Kumar R. " Phosphatonins" and the regulation of phosphorus homeostasis. Am. J. Physiol. Renal. Physiol. 2005, 289:F1170-F1182.
12. Rowe P.S. The wrickkened pathways of FGF23, MEPE and PHEX. Crit. Rev. Oral Biol. Med. 2004, 15:264-281.
13. Martin A., David V., Laurence J.S., Schwarz P.M., Lafer E.M., Hedge A.M., Rowe P.S. Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP. Endocrinology 2008, 149:1757-1772.
14. Rowe P.S., Matsumoto N., Jo O.D., Shih R.N., Oconnor J., Roudier M.P., Bain S., Liu S., Harrison J., Yanagawa N. Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin. Bone 2006, 39:773-786.
15. Rowe P.S., Kumagai Y., Gutierrez G., Garrett I.R., Blacher R., Rosen D., Cundy J., Navvab S., Chen D., Drezner M.K., Quarles L.D., Mundy G.R. MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone 2004, 34:303-319.
16. Liu S., Rowe P.S., Vierthaler L., Zhou J., Quarles L.D. Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity. J. Endocrinol. 2007, 192:261-267.
17. Sprowson A.P., McCaskie A.W., Birch M.A. ASARM-truncated MEPE and AC-100 enhance osteogenesis by promoting osteoprogenitor adhesion. J. Orthop. Res. 2008, 26:1256-1262.
18. Ogbureke K.U., Fisher L.W. Expression of SIBLINGs and their partner MMPs in salivary glands. J. Dent. Res. 2004, 83:664-670.
19. Ogbureke K.U., Fisher L.W. Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs). Kidney Int. 2005, 68:155-166.
20. Wang H.G., Kawashima N., Iwata T., Xu J., Takahashi S., Sugiyam T., Suda H. MEPE is activated by furin and promotes cell adhesion in dental pulp. J. Dent. Res. 2010.
21. Arany S., Nakata A., Kameda T., Koyota S., Ueno Y., Sugiyama T. Phenotype properties of a novel spontaneously immortalized odontoblast-lineage cell line. Biochem. Biophys. Res. Commun. 2006, 342:718-724.
22. Fisher L.W., Fedarko N.S. Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect. Tissue Res. 2003, 44(Suppl. 1):33-40.
23. Butler W.T., Ritchie H. The nature and functional significance of dentin extracellular matrix proteins. Int. J. Dev. Biol. 1995, 39:169-179.
24. He G., Dahl T., Veis A., George A. Nucleation of apatite crystals in vitro by self-assembled dentin matrix protein 1. Nat. Mater. 2003, 2:552-558.
25. Dong J., Gu T., Jeffords L., MacDougall M. Dentin phosphoprotein compound mutation in dentin sialophosphoprotein causes dentinogenesis imperfecta type III. Am. J. Med. Genet. A 2005, 132A:305-309.
26. Kim J.W., Hu J.C., Lee J.I., Moon S.K., Kim Y.J., Jang K.T., Lee S.H., Kim C.C., Hahn S.H., Simmer J.P. Mutational hot spot in the DSPP gene causing dentinogenesis imperfecta type II. Hum. Genet. 2005, 116:186-191.
27. Kim J.W., Nam S.H., Jang K.T., Lee S.H., Kim C.C., Hahn S.H., Hu J.C., Simmer J.P. A novel splice acceptor mutation in the DSPP gene causing dentinogenesis imperfecta type II. Hum. Genet. 2004, 115:248-254.
28. Malmgren B., Lindskog S., Elgadi A., Norgren S. Clinical, histopathologic, and genetic investigation in two large families with dentinogenesis imperfecta type II. Hum. Genet. 2004, 114:491-498.
29. Rajpar M.H., Koch M.J., Davies R.M., Mellody K.T., Kielty C.M., Dixon M.J. Mutation of the signal peptide region of the bicistronic gene DSPP affects translocation to the endoplasmic reticulum and results in defective dentine biomineralization. Hum. Mol. Genet. 2002, 11:2559-2565.
30. Qin C., Brunn J.C., Cook R.G., Orkiszewski R.S., Malone J.P., Veis A., Butler W.T. Evidence for the proteolytic processing of dentin matrix protein 1. Identification and characterization of processed fragments and cleavage sites. J. Biol. Chem. 2003, 278:34700-34708.
31. Steiglitz B.M., Ayala M., Narayanan K., George A., Greenspan D.S. Bone morphogenetic protein-1/Tolloid-like proteinases process dentin matrix protein-1. J. Biol. Chem. 2004, 279:980-986.
32. Qin C., Baba O., Butler W.T. Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit. Rev. Oral Biol. Med. 2004, 15:126-136.
33. Boukpessi T., Septier D., Bagga S., Garabedian M., Goldberg M., Chaussain-Miller C. Dentin alteration of deciduous teeth in human hypophosphatemic rickets. Calcif. Tissue Int. 2006, 79:294-300.
34. Igarashi M., Kamiya N., Ito K., Takagi M. In situ localization and in vitro expression of osteoblast/osteocyte factor 45 mRNA during bone cell differentiation. Histochem. J. 2002, 34:255-263.
35. Giancotti F.G., Ruoslahti E. Integrin signaling. Science 1999, 285:1028-1032.
36. Plow E.F., Haas T.A., Zhang L., Loftus J., Smith J.W. Ligand binding to integrins. J. Biol. Chem. 2000, 275:21785-21788.
37. Altroff H., van der Walle C.F., Asselin J., Fairless R., Campbell I.D., Mardon H.J. The eighth FIII domain of human fibronectin promotes integrin alpha5beta1 binding via stabilization of the ninth FIII domain. J. Biol. Chem. 2001, 276:38885-38892.
38. Hayashibara T., Hiraga T., Yi B., Nomizu M., Kumagai Y., Nishimura R., Yoneda T. A synthetic peptide fragment of human MEPE stimulates new bone formation in vitro and in vivo. J. Bone Miner. Res. 2004, 19:455-462.